BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 11, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 22, 2001
View Archived Issues
PROGRESS trials show Aceon/diuretic combination reduces recurrent stroke by 50%
Read More
Technology applicable to dengue vaccine available for licensing
Read More
Licensing opportunity from NIH: chimeric protein with potential as antiinfective therapeutic
Read More
GSK committed to development of infectious disease treatments
Read More
Valdecoxib compares favorably to conventional NSAIDs in terms of both efficacy and safety
Read More
KS Biomedix to acquire Avicenna; obtains exclusive license to antibody products
Read More
Major beneficial effects reported for DP-b99 in focal and global cerebral ischemia
Read More
Orally active SARM exerts anabolic effects on bone and muscle in androgen-deficient rats
Read More
Phase II clinical trial of ISIS-104838 commences in patients with psoriasis
Read More
Amylin's AC-2993 reaches endpoint in type 2 diabetes trial
Read More
Recruitment begins in phase II trial of BBR-3464 for pancreatic cancer
Read More
Novel class of molecules --the SGRMs-- with potential therapeutic benefits over glucocorticoids
Read More
Genentech returns rights to respiratory compounds to Inspire
Read More
Second multicenter phase I/II trial of GVAX for NSCLC
Read More
Phase II data on Insmed's lead product discussed at ENDO 2001
Read More
Prescient NeuroPharma identifies neurotrophic factor genes
Read More
Numerous studies published recently on soon-to-be-introduced ARB olmesartan
Read More
Viragen cleared to begin clinical trials of Omniferon for MS in the U.K.
Read More
Oxford GlycoSciences and NeoGenesis enter drug discovery alliance
Read More
IntraDose plus systemic chemotherapy evaluated in H&N cancer patients
Read More
GW-471558: a new azasordarin with potent anticandidal activity
Read More
Fujisawa describes new NO production inhibitors and their uses
Read More
Italian research group discovers protease inhibitors useful for HCV
Read More
Pharmacia presents new oxazolidinone antibacterial agents
Read More
Novel compounds act as antagonists at 5-ht6 receptors and are useful for Rx of CNS disorders
Read More
Vasopressin antagonists reported by Ortho-McNeil in patent literature
Read More
NMDA antagonists with anticonvulsant activity synthesized at Merz
Read More
